CD55 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD55 monoclonal antibodies for research focused on understanding CD55 function and regulation. CD55 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD55, also known as decay-accelerating factor (DAF), plays a crucial role in the regulation of the complement system, helping to protect cells from complement-mediated lysis. CD55 expression is vital in maintaining immune homeostasis and preventing excessive inflammation. Dysregulation of CD55 has been implicated in various diseases, including autoimmune disorders and cancer, making it a significant target for therapeutic interventions. CD55 monoclonal antibodies enable detailed investigation of molecular pathways and cellular mechanisms. Understanding CD55's role in disease progression can lead to improved diagnostic and treatment strategies. CD55 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge and developing potential therapeutic approaches.